BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Do the Math - Forget price per share. Market Cap evaluation truly shows where BPAX belongs.

In order to help with your own due diligence follow the link and see where BPAX sits in the list of 311 Biotech and Drug companies. Follow the links to the companies BPAX is competing against and look at their products and pipeline. For those who aren't already sold on BPAX it will be your AHA! momment.


Biotech and Drug companies

I have provided a list of companies with their Market Cap, Annual Revenue and Annual Net Income. In my honest opinion BPAX arguably should have a greater market cap then most if not all the listed companies,as BPAX is a much more diversified company.


Company = Market Cap / Annual Revenue / Annual Net Income ($ MILLION)

Biosante = 59.37 / 2.47 / -46.20
YM Bioscience = 189.07 / 1.01 / -40.04
Cell therapeutics = 221.68 / 0.32 / -147.56
Cadence Pharma = 255.73 / 0 / -56.54
Corcept Thearap. = 264.49 / 0 / -25.97
Navidea Biopharma = 265.36 / 10.7 / -58.09
Anthera Pharma = 286.76 / 0 / -40.41
Progenics Pharma = 287.32 / 7.35 / -69.72
Raptor Pharma = 299.54 / 0 / -37.19
Chelsea Therap. = 312.95 / 0 / -37.33
Clovis Oncology = 314.99 / 0 / -37.83
ZIOPHARM Oncology = 349.10 / 0 / -32.67
MannKind Corp. = 359.87 / 0.9 / -170.56
Lexicon Pharma = 493.01 / 4.91 / -101.78